N-(2,2,6,6-Tetramethylpiperidin-4-yl)acrylamide

Catalog No. :
ACZVXK602
CAS No. :
31582-37-3
Molecular Formula :
C12H22N2O
Molecular Weight :
210.32

IUPAC Name:N-(2,2,6,6-tetramethylpiperidin-4-yl)acrylamide

N-(2,2,6,6-Tetramethylpiperidin-4-yl)acrylamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$104.00Login to see priceIn stockInquiry
1g97%$207.00Login to see priceIn stockInquiry
5g97%$916.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,2,6,6-Tetramethylpiperidin-4-yl)acrylamide
IUPAC NameN-(2,2,6,6-tetramethylpiperidin-4-yl)acrylamide
MDL No.MFCD12091533
Molecular FormulaC12H22N2O
Molecular Weight210.32
SMILESC=CC(NC1CC(C)(C)NC(C)(C)C1)=O
InChI KeyREKHXRWEQQXQLZ-UHFFFAOYSA-N
SynonymN-(2,2,6,6-Tetramethyl-piperidin-4-yl)-acrylamide;N-(2,2,6,6-Tetramethyl-4-piperidinyl)-2-propenamide;2-Propenamide, N-(2,2,6,6-tetramethyl-4-piperidinyl)-;N-(2,2,6,6-tetramethylpiperidin-4-yl)prop-2-enamide
CAS No.31582-37-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZVXK602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXBGQ986 route compound structure diagram
    ACXBGQ98636768-62-4
  4. Then
  5. ACZVXK602 route product structure diagram
    ACZVXK60231582-37-3 In Stock
Inquiry

2. ACZVXK602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXBGQ986 route compound structure diagram
    ACXBGQ98636768-62-4
  4. Then
  5. ACZVXK602 route product structure diagram
    ACZVXK60231582-37-3 In Stock
Inquiry

Comments (0)